Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/06/2003 | US20030206882 Ready-to-use teat dip also containing a sulfonate or sulfate hydrotrope solubilizer; mineral acid-free |
11/06/2003 | US20030206881 Phospholipidic composition as well as the use thereof |
11/06/2003 | US20030206873 1,4-di(substituted phenyl)- derivatives; adapted for delayed release |
11/06/2003 | US20030206870 Pharaceutical aerosol composition |
11/06/2003 | US20030206869 Delivery of antidepressants through an inhalation route |
11/06/2003 | US20030206867 Spray that delivers unit doses that are highly accurate as to the volume discharged and which leave no significant quantity of the composition in the delivery means. |
11/06/2003 | US20030206866 1,2,3,6-Tetrahydropyrimidine-2-one compositions, articles and therapeutic methods for upper airway breathing disorders |
11/06/2003 | US20030206863 Methods of resonance imaging using ultrasonic energy |
11/06/2003 | US20030206859 Nanometer-sized carrier medium |
11/06/2003 | US20030205582 Fluid delivery device having an electrochemical pump with an anionic exchange membrane and associated method |
11/06/2003 | US20030205229 Drug delivery apparatus |
11/06/2003 | CA2496454A1 Transdermal analgesic systems with reduced abuse potential |
11/06/2003 | CA2487245A1 An injection made from ixeris sonchifolia hance for treatment of cardio-cerebral vascular diseases and fundus diseases and method of producing thereof |
11/06/2003 | CA2484057A1 Prevention of myocardial infarction induced ventricular expansion and remodeling |
11/06/2003 | CA2483980A1 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
11/06/2003 | CA2483635A1 Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head |
11/06/2003 | CA2483505A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription |
11/06/2003 | CA2483265A1 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease |
11/06/2003 | CA2483103A1 Pharmaceutical composition containing lamotrigine particles of defined morphology |
11/06/2003 | CA2483102A1 Treatment and prevention of pulmonary conditions |
11/06/2003 | CA2483092A1 Tolterodine salts |
11/06/2003 | CA2482941A1 Microparticle pharmaceutical compositions for intratumoral delivery |
11/06/2003 | CA2482936A1 Capsule preparation |
11/06/2003 | CA2482932A1 Colloidal suspension of submicronic particles for delivering active principles and method for preparing same |
11/06/2003 | CA2482711A1 Cosmetic composition for promoting hair growth and/or preventing or delaying hair loss |
11/06/2003 | CA2482019A1 Use of conjugated linoleic acid or derivative thereof in the treatment of influenza |
11/06/2003 | CA2480130A1 Method for producing crystals from active ingredients in medicaments and the use thereof in pharmaceutical formulations |
11/06/2003 | CA2479943A1 Method for reduction of residual organic solvent in carbomer |
11/05/2003 | EP1358930A1 Microcapsules (XVII) |
11/05/2003 | EP1358883A1 Re-epithelializing pharmaceutical compositions containing xanthan gum |
11/05/2003 | EP1358876A1 Microcapsules containing anti-acne agents |
11/05/2003 | EP1358875A1 Colored hard capsules |
11/05/2003 | EP1358874A1 Peptide/lipid complex formation by co-lyopholization |
11/05/2003 | EP1358873A1 Mesoporous silica having controlled-release on-off control function, production method thereof and method using same |
11/05/2003 | EP1358872A1 Use of mixtures of active compounds comprising azelaic acid and glycyrrhetic acid in the treatment of acne |
11/05/2003 | EP1358868A2 Cosmetic composition for increasing hair growth and/or for preventing or delaying hair loss |
11/05/2003 | EP1358207A1 Sol-fusin: use of gp64-6his to catalyze membrane fusion |
11/05/2003 | EP1357977A2 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia |
11/05/2003 | EP1357975A1 Medicament compositions with negligible side-effects containing betamimetics |
11/05/2003 | EP1357974A1 Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof |
11/05/2003 | EP1357920A2 Compositions and method of tissue superoxygenation |
11/05/2003 | EP1357903A2 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- 2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO b]THIOPHENE AND SALTS THEREOF |
11/05/2003 | EP1357902A2 Therapeutic agents complexed with calcium phosphate and encased by casein |
11/05/2003 | EP1357901A2 Process |
11/05/2003 | EP1357900A2 Process for production of nanoparticles and microparticles by spray freezing into liquid |
11/05/2003 | EP1357899A2 Oral itraconazole formulations and methods of making the same |
11/05/2003 | EP1357898A2 Improved controlled release oral dosage form |
11/05/2003 | EP1357897A2 Delivery of biologically active agents |
11/05/2003 | EP1357896A1 Membrane for encapsulation chamber of cells producing at least a biologically active substance and bioartificial organ comprising same |
11/05/2003 | EP1357895A2 Vaccine composition and stabilisation method |
11/05/2003 | EP1357893A2 Acid cosmetic, dermatological and pharmaceutical agents |
11/05/2003 | EP1357892A1 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same |
11/05/2003 | EP1357873A2 Therapeutic film forming composition and treatment system therefor |
11/05/2003 | EP1357871A1 Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate |
11/05/2003 | EP1357870A1 Bioadhesive cell foam film of sustained-release delivery |
11/05/2003 | EP1357855A2 Ophthalmic compositions for treating ocular hypertension |
11/05/2003 | EP1357811A1 Composition and method for smoke detoxification |
11/05/2003 | EP1189749B1 Composite laminate and method for its production |
11/05/2003 | EP1181930B1 Patch |
11/05/2003 | EP1176961B1 Nicotine delivery systems |
11/05/2003 | EP1154762B1 Pharmaceutical capsule compositions containing loratadine and pseudoephedrine |
11/05/2003 | EP1123342B1 Method for the production of spherical microparticles consisting totally or partly of at least one water-insoluble polyglucan containing branches and microparticles produced according to said method |
11/05/2003 | EP1105141B1 Phosphatidylcholine as a medicament for the protection of mucosa |
11/05/2003 | EP1061942B1 Topical composition containing human epidermal growth factor |
11/05/2003 | EP1051194B9 Process for making absorbable microparticles |
11/05/2003 | EP1024791B1 Medical emulsion lubricant |
11/05/2003 | EP1023069B1 Nicotine compositions and methods of formulation thereof |
11/05/2003 | EP0973527B1 Extended release formulations of clarithromycin |
11/05/2003 | EP0971703B9 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
11/05/2003 | EP0921807B1 Hydrogenous medicament |
11/05/2003 | EP0871432B1 Use of a composition containing polyether block copolymers |
11/05/2003 | EP0863747B1 Stimulation of hair follicles |
11/05/2003 | EP0839039B1 Paroxetine controlled release compositions |
11/05/2003 | EP0814835B1 Method for enhancing immunogenicity, product obtained and pharmaceutical composition |
11/05/2003 | EP0813413B1 Corticosteroid-containing foam |
11/05/2003 | EP0777679B1 Delivery of nucleic acids |
11/05/2003 | CN2584186Y Compound gel adhesive plaster |
11/05/2003 | CN1454094A Minari extract for preventing the induction and metast asis of cancer by carcinogens contained in cigarette smoke, fermented foods or alcoholic drinks |
11/05/2003 | CN1454091A Immunostimulatory nucleic acids |
11/05/2003 | CN1454085A Clear aqueous anaesthetic composition |
11/05/2003 | CN1454084A Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion |
11/05/2003 | CN1454082A Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
11/05/2003 | CN1453356A Natto kinase purifying process and its freeze dried powder for injection |
11/05/2003 | CN1453293A Solid phase synthesis method of peptide-spacer-lipoid conjugate, synthesized conjugate and targeting liposome containing the conjugate |
11/05/2003 | CN1453043A Microbiological cellulose injury dressing for treating chronic injury |
11/05/2003 | CN1453036A Quick-acting ointment for treating burns, scalds and knife wound |
11/05/2003 | CN1453034A Chinese medicine composition for treating heart, kidney and multiple-organ failure and its prepn |
11/05/2003 | CN1453033A Freeze dried isatis root powder for injection and its prepn |
11/05/2003 | CN1453008A Flexible fabric bandage with Chinese medicine and its prepn |
11/05/2003 | CN1453006A Multifunctional treating and beautifying Chinese medicine acupoint plaster and its making process |
11/05/2003 | CN1452994A Multifunctional paster |
11/05/2003 | CN1452983A Delayed-releasing compound diclofenac sodium prepn |
11/05/2003 | CN1452982A Mucosa administrated Ribavirin prepn for preventing & curing SARS and its prepn process |
11/05/2003 | CN1452979A Medicine composition with anti-inflammatory effect and its production process |
11/05/2003 | CN1452977A Clarithromycin injection |
11/05/2003 | CN1452975A Roxithromycin injection |
11/05/2003 | CN1452974A Globeflower powder for injection and its prepn |
11/05/2003 | CN1452966A Compound Atenolol-Nifedipine slow releasing prepn |
11/05/2003 | CN1452965A Snuff |
11/05/2003 | CN1452964A Nasal spray agent |